Exscientia Balance Sheet Health
Financial Health criteria checks 5/6
Exscientia has a total shareholder equity of £296.0M and total debt of £299.0K, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are £437.8M and £141.7M respectively.
Key information
0.1%
Debt to equity ratio
UK£299.00k
Debt
| Interest coverage ratio | n/a |
| Cash | UK£292.78m |
| Equity | UK£296.04m |
| Total liabilities | UK£141.74m |
| Total assets | UK£437.78m |
Recent financial health updates
Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation
Jul 17
Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Recent updates
Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others
Aug 08Here's Why We're Watching Exscientia's (NASDAQ:EXAI) Cash Burn Situation
Jul 17Exscientia: Too Much Pessimism
Jun 10Exscientia: Drug Discovery Platform Attracting Partners And Cash
May 22Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade)
Feb 26Is Exscientia (NASDAQ:EXAI) In A Good Position To Invest In Growth?
Jan 11Earnings Update: Exscientia plc (NASDAQ:EXAI) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 12New Forecasts: Here's What Analysts Think The Future Holds For Exscientia plc (NASDAQ:EXAI)
Aug 31We're Keeping An Eye On Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Aug 25Broker Revenue Forecasts For Exscientia plc (NASDAQ:EXAI) Are Surging Higher
Jul 21Exscientia (NASDAQ:EXAI) Is In A Good Position To Deliver On Growth Plans
Apr 22We're Not Very Worried About Exscientia's (NASDAQ:EXAI) Cash Burn Rate
Dec 30The Exscientia plc (NASDAQ:EXAI) Analysts Have Been Trimming Their Sales Forecasts
Aug 31Exscientia: Using AI To Power Drug Development
Aug 15Companies Like Exscientia (NASDAQ:EXAI) Can Afford To Invest In Growth
May 29Exscientia: Drug Discovery Using AI For Sanofi And Self-Owned Pipeline
Apr 12Bullish: Analysts Just Made A Sizeable Upgrade To Their Exscientia plc (NASDAQ:EXAI) Forecasts
Jan 09Financial Position Analysis
Short Term Liabilities: EXAI's short term assets (£340.2M) exceed its short term liabilities (£57.4M).
Long Term Liabilities: EXAI's short term assets (£340.2M) exceed its long term liabilities (£84.4M).
Debt to Equity History and Analysis
Debt Level: EXAI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if EXAI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EXAI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EXAI has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 60.3% each year.